PCDPrivate Comps Data

Company record · updated August 5, 2026

Fractyl Health, Inc.: 7 valuation observations from SEC filings

Every row below names the filing it came from. Coverage for this company runs December 14, 2023 to December 14, 2023.

7observations
1source filings
7verified rows
2023-12-14most recent as-of date

Source rails for this company: S-1 charter round (7).

As ofMeasureValueReported byTier What the filing saysAccession
2023-12-14 Series F price per share 8.3843 USD VERIFIED "Original Issue Price" defined for Series F 000119312523295433
2023-12-14 Series E price per share 8.3843 USD VERIFIED "Original Issue Price" defined for Series E 000119312523295433
2023-12-14 Series D price per share 4.2893 USD VERIFIED "Original Issue Price" defined for Series D 000119312523295433
2023-12-14 Series C-2 price per share 3.6667 USD VERIFIED "Original Issue Price" defined for Series C-2 000119312523295433
2023-12-14 Series C-1 price per share 3.0756 USD VERIFIED "Original Issue Price" defined for Series C-1 000119312523295433
2023-12-14 Series B price per share 2.2356 USD VERIFIED "Original Issue Price" defined for Series B 000119312523295433
2023-12-14 Series A price per share 1.266 USD VERIFIED "Original Issue Price" defined for Series A 000119312523295433

Reading these figures

A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price. The capabilities page states the full limits.